Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)

Clinical trial NCT00233519 · COMPLETED

Trial details

NCT number: NCT00233519
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy

Start date: 2005-11-01
Primary completion: 2008-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.